› Forums › Cutaneous Melanoma Community › Answer to Jend013 on brain mets.
- This topic is empty.
- Post
-
- December 23, 2020 at 4:02 pm
I tried using reply button on your post but I couldn’t see what I was typing and links didn’t work that I gave you so I will try again here. Response rate in ABC trial was 59% for non previous use of targeted therapy patients vs 51% if they had had targeted therapy in the past. NKTR-214 didn’t look at brain met patients in early trials and they haven’t gotten approval from FDA yet. It has been a couple of years of everyone waiting and there were some issue with reporting data in the past and accuracy. Here are the two links again from your post. https://www.nejm.org/doi/pdf/10.1056/NEJMoa1805453 https://ascopost.com/videos/esmo-2019-congress/georgina-long-on-melanoma-brain-metastases/
- You must be logged in to reply to this topic.